Literature DB >> 19580437

Hospital-wide methicillin-resistant Staphylococcus aureus control program: A 5-year follow-up.

Michal Y Chowers1, Yossi Paitan, Bat Sheva Gottesman, Beatris Gerber, Yona Ben-Nissan, Pnina Shitrit.   

Abstract

We investigated the influence of different interventions (active surveillance, contact isolation, monitoring, and rapid diagnostic testing) on the number of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia cases. An interrupted time-series analysis was used. MRSA bacteremia cases were reduced by 70% when all interventions were in place. We proved monitoring to be an essential component.

Entities:  

Mesh：

Year:  2009        PMID： 19580437     DOI： 10.1086/599019

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  4 in total

1.  Evaluation of the NanoCHIP® Infection Control Panel test for direct detection and screening of methicillin-resistant Staphylococcus aureus (MRSA), Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria and vancomycin-resistant Enterococcus (VRE).

Authors:  Judith Weiss; Haia Arielly; Nirit Ganor; Yossi Paitan
Journal:  Infection       Date:  2015-03-01       Impact factor: 3.553

2.  Multiplex real-time PCR assay for detection of methicillin-resistant Staphylococcus aureus (MRSA) strains suitable in regions of high MRSA endemicity.

Authors:  Jeong-Uk Kim; Choong-Hwan Cha; Hae-Kyong An; Ho-Jun Lee; Mi-Na Kim
Journal:  J Clin Microbiol       Date:  2012-12-26       Impact factor: 5.948

3.  Methicillin-Resistant Staphylococcus aureus Recovered from Healthcare- and Community-Associated Infections in Egypt.

Authors:  Mohamed Abdel-Maksoud; Mona El-Shokry; Ghada Ismail; Soad Hafez; Amani El-Kholy; Ehab Attia; Maha Talaat
Journal:  Int J Bacteriol       Date:  2016-06-28

4.  Cost Analysis of an Intervention to Prevent Methicillin-Resistant Staphylococcus Aureus (MRSA) Transmission.

Authors:  Michal Chowers; Yehuda Carmeli; Pnina Shitrit; Asher Elhayany; Keren Geffen
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.